Beijing Airdoc Technology Co., Ltd. (HKG:2251)

Market Cap	1.22B -19.5%
Revenue (ttm)	192.81M +10.8%
Net Income	-27.79M
EPS	-0.27
Shares Out	102.38M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	46,900
Average Volume	172,015
Open	12.10
Previous Close	11.80
Day's Range	11.41 - 12.30
52-Week Range	10.02 - 16.00
Beta	0.76
RSI	59.96
Earnings Date	Mar 31, 2026

About Beijing Airdoc Technology

Beijing Airdoc Technology Co., Ltd. provides artificial intelligence (AI) empowered retina-based early detection, diagnosis, and health risk assessment solutions in Mainland China and internationally. The company offers a software as a medical device (SaMD) product, Airdoc-AIFUNDUS, which is an AI-assisted diagnosis of retinal detection product that is available in three versions comprising version 1.0 for the diagnosis of diabetic retinopathy, version 2.0 that address various fundus diseases, and version 3.0 for the diagnosis of pathological m...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2015
• Employees: 193
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2251

Financial Performance

In 2025, Beijing Airdoc Technology's revenue was 173.26 million, an increase of 10.80% compared to the previous year's 156.37 million. Losses were -24.98 million, -90.22% less than in 2024.

Financial numbers in CNY